[1] 国家卫生健康委合理用药专家委员会.2020年全国细菌耐药监测报告[R]. http://www.carss.cn/sys/Htmls/dist/index.html#/. [2] Lin Y T, Liu C J, Chen T J, et al. Pyogenic liver abscess as the initial manifestation of underlying hepatocellular carcinoma[J]. Am J Med, 2011, 124(12):1158-1164. [3] Lee C R, Lee J H, Park K S, et al. Global dissemination of carbapenemase-producing klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods[J]. Front Microbiol, 2016, 13(7):895. [4] Hennequin C, Robin F. Correlation between antimicrobial resistance and virulence in Klebsiella pneumoniae[J]. Eur J Clin Microbiol Infect Dis, 2016,35(3):333-341. [5] Gu D, Dong N, Zheng Z, et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study[J]. Lancet Infect Dis, 2018,18(1):37-46. [6] Guo Y, Wang S, Zhan L, et al. Microbiological and clinical characteristics of hypermucoviscous klebsiella pneumoniae isolates associated with invasive infections in China[J]. Front Cell Infect Microbiol, 2017, 1(7):24. [7] Choby J E, Howard-Anderson J, Weiss D S. Hypervirulent Klebsiella pneumoniae clinical and molecular perspectives[J]. J Intern Med, 2020,287(3):283-300. [8] 张杰,喻华.四川省人民医院肝脓肿患者血培养分离肺炎克雷伯杆菌铁系统基因携带情况的分析[J].中国循证医学杂志,2017,178:907-909. [9] Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing.30th Edition. CLSI supplement M100[M]. Wayne, PA:Clinical and Laboratory Standards Institute, 2020:38-48. [10]Cusumano J A, Caffrey A R, Daffinee K E, et al. Weak biofilm formation among carbapenem-resistant Klebsiella pneumoniae[J]. Diagn Microbiol Infect Dis, 2019,95(4): 114877. [11]Machuca A, Milagres A M. Use of CAS-agar plate modified to study the effect of different variables on the siderophore production by Aspergillus[J]. Lett Appl Microbiol,2003,36(3):177-181. [12]Poirel L, Walsh T R, Cuvillier V, et al. Multiplex PCR for detection of acquired carbapenemase genes[J]. Diagn Microbiol Infect Dis, 2011,70(1):119-123. [13]李睿,辛力华,张青,等.碳青霉烯类耐药肺炎克雷伯菌ERIC-PCR指纹图谱分型的研究[J].解放军医药杂志,2018,30(11):102-105. [14]吕继帆.肺炎克雷伯菌感染致脓毒血症及多发脓肿诊治探讨[J].临床误诊误治,2018,31(3):15-19. [15]Zhang Y, Jin L, Ouyang P, et al. Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis[J]. J Antimicrob Chemother, 2020,75(2):327-336. [16]Shon A S, Bajwa R P, Russo T A. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed[J]. Virulence, 2013,4(2):107-118. [17]Lin Y C, Lu M C, Tang H L, et al. Assessment of hypermucoviscosity as a virulence factor for experimental Klebsiella pneumoniae infections: comparative virulence analysis with hypermucoviscosity-negative strain[J]. BMC Microbiol, 2011,11:50. [18]Qu T T, Zhou J C, Jiang Y, et al. Clinical and microbiological characteristics of Klebsiella pneumoniae liver abscess in East China[J]. BMC Infect Dis, 2015,15:161. [19]Zhang Y, Zhao C, Wang Q, et al. High prevalence of hypervirulent klebsiella pneumoniae infection in china: geographic distribution, clinical characteristics, and antimicrobial resistance[J]. Antimicrob Agents Chemother, 2016, 60(10): 6115-6120. |